Tue.Jan 10, 2023

article thumbnail

JPM23: Pfizer entering the 'most important' 18-month stretch in company history, CEO says

Fierce Pharma

JPM23: Pfizer entering the 'most important' 18-month stretch in company history, CEO says. esagonowsky. Tue, 01/10/2023 - 08:51.

324
324
article thumbnail

Hinge Health Introduces Physical Therapy House Call Service

MedCity News

The in-home service is meant to complement the company’s virtual care. Members are able to book appointments within one to two business days and receive in-person assessments of their mobility, as well as any fall hazards in their home.

129
129
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share

Fierce Pharma

JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share. aarmstrong. Tue, 01/10/2023 - 10:24.

Marketing 296
article thumbnail

Nest Genomics Raises $8.5M to Increase Access to Patients’ Genetic Information

MedCity News

Nest Genomics just closed a $8.5 million seed financing round. The company provides the software infrastructure needed for health systems, clinics, drugmakers and payers to launch and scale genomic programs. It also provides tools for patients to easily access their genetic information.

Patients 128
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals

Fierce Pharma

JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals. kdunleavy. Tue, 01/10/2023 - 06:24.

296
296
article thumbnail

From JPM Week: Trends That Life Science Experts Are Watching in 2023

MedCity News

Boston Consulting Group hosted a panel during the annual J.P. Morgan Healthcare Conference in which Merck’c chief strategy officer, a healthcare leader from Goldman Sachs, an investment executive and a senior medical devices executive from Medtronic weighed in on trends the life sciences industry can expect to see in 2023.

More Trending

article thumbnail

BioNTech Dives Deeper Into Digital With £362M Buyout of AI Startup InstaDeep

MedCity News

BioNTech says its InstaDeep acquisition will help it expand its use of artificial intelligence in drug discovery and development. The startup specializes in a type of machine learning called reinforcement learning.

article thumbnail

Spiral winds up for phase 2 sustained-release steroid trial with $8M financing

Fierce Pharma

Spiral winds up for phase 2 sustained-release steroid trial with $8M financing. ntaylor. Tue, 01/10/2023 - 10:31.

246
246
article thumbnail

BioNTech buys UK-based AI startup InstaDeep in £562m deal

pharmaphorum

mRNA specialist BioNTech has driven its partnership with UK artificial intelligence InstaDeep into top gear, agreeing to buy the company outright in a cash and equity deal that values it at up to £562 million ($683 million). The deal , billed as BioNTech’s largest to date and unveiled at the JP Morgan healthcare conference today, includes $362 million upfront with another £200 million on offer if performance targets are met.

article thumbnail

JPM23: Bayer hikes sales targets for Kerendia, Nubeqa to $3B each

Fierce Pharma

JPM23: Bayer hikes sales targets for Kerendia, Nubeqa to $3B each. kdunleavy. Tue, 01/10/2023 - 15:42.

Sales 263
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

A VC’s take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca

MedCity News

Maina Bhaman, a board member of CinCor Pharma reflects on the news from Monday that AstraZeneca is acquiring the Massachusetts startup to bring another option for patients with resistant hypertension.

Pharma 116
article thumbnail

JPM23: Sanofi has reached the 'steady state' Paul Hudson envisioned years ago, CEO says

Fierce Pharma

JPM23: Sanofi has reached the 'steady state' Paul Hudson envisioned years ago, CEO says. zbecker. Tue, 01/10/2023 - 20:33.

261
261
article thumbnail

LeanTaaS Acquires Hospital IQ to Create $1B Healthcare Automation Company

MedCity News

LeanTaaS acquired healthcare automation company Hospital IQ. The two companies made the deal because their products complement each other — Hospital IQ provides staff optimization solutions, while LeanTaaS makes software to optimize capacity for operating rooms, infusion centers and inpatient beds.

article thumbnail

Celltrion signs up to support Rani’s oral biosimilar copy of J&J’s Stelara, lands right of first negotiation

Fierce Pharma

Celltrion signs up to support Rani’s oral biosimilar copy of J&J’s Stelara, lands right of first negotiation. ntaylor. Tue, 01/10/2023 - 10:24.

130
130
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

EY: While Nearly All Healthcare Companies Have a Health Equity Strategy, Most Are New

MedCity News

About 98% of healthcare companies have a health equity strategy, but nearly 60% initiated the strategy in just the last five years and 34% created it during the Covid-19 pandemic, the EY report shows.

article thumbnail

Biogen, scrapping for SMA market share, bets $10M on implant to improve delivery of Spinraza

Fierce Pharma

Biogen, scrapping for SMA market share, bets $10M on implant to improve delivery of Spinraza. ntaylor. Tue, 01/10/2023 - 06:40.

Marketing 130
article thumbnail

Lack of medicines in Greece and the solution of Generics

Pharmatutor

Lack of medicines in Greece and the solution of Generics. admin. Tue, 01/10/2023 - 15:46. Georgios-Marios Bolmpasis. MPharm Student University of Athens. Vice President of Pharmacy Students Association(Athens).

Medicine 100
article thumbnail

Cognos strikes SPAC merger to fund implantable drug delivery R&D

Fierce Pharma

Cognos strikes SPAC merger to fund implantable drug delivery R&D. ntaylor. Tue, 01/10/2023 - 10:27.

130
130
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues. Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets

article thumbnail

AstraZeneca to buy US-based CinCor Pharma for $1.8bn

Pharmaceutical Technology

AstraZeneca has signed a definitive agreement to buy US-based biopharmaceutical company CinCor Pharma in a deal valued at about $1.8bn. Under the deal, the company will initiate a tender offer to purchase all the outstanding shares of CinCor Pharma for $26 per share in cash. The transaction also includes a non-tradable contingent value right of $10 per share in cash which will be paid after a specified regulatory submission of CinCor’s lead drug candidate, baxdrostat (CIN-107).

Pharma 97
article thumbnail

JPM23: J&J stayed in the back seat during Horizon bidding war, CEO says

Fierce Pharma

JPM23: J&J stayed in the back seat during Horizon bidding war, CEO says. fkansteiner. Tue, 01/10/2023 - 12:39.

100
100
article thumbnail

JP Morgan 2023 – Day 2

pharmaphorum

Tuesday brings the on-site part of Fierce’s JPM event as well as day 2 of the Informa Biotech Showcase. We’ll do our best to surf between the two, as well as providing remote updates where we can from the main event. Fierce’s event “The long haul: How pharma and healthcare can survive in 2023” will feature guests from Bayer, Takeda, Genentech, and more.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Potential blockbuster drugs to watch in 2023

European Pharmaceutical Review

Clarivate Plc has released its Drugs to Watch 2023 report — among 70 of the drugs highlighted, including potential blockbuster drugs, the majority were revealed to be personalised medicines. The report offers predictive analysis of drugs entering the market or launching key indications in 2023. Treatments identified in the report are predicted to be potential blockbuster drugs by 2027 or have potential to serve unmet patient needs for millions of patients worldwide.

article thumbnail

7 Steps to Getting Your Desired Medical Sales Results

MedReps

A new year means new goals to meet for medical sales reps. Regardless of your niche, whether it’s medical equipment, prescription drugs, medical devices or even biotech, you have to plan in advance if you want to meet your sales targets. 7 Steps to Getting Your Desired Medical Sales Results. Those aren’t the only goals to shoot for, either. There are plenty of others that you can set for yourself in order to grab those medical sales results.

article thumbnail

Makcur Laboratories Ltd.- Openings for QC/ Engineering / QA/ Microbiology/ Regulatory Affairs- Apply Now

Pharma Pathway

Makcur Laboratories Ltd.- Openings for QC/ Engineering / QA/ Microbiology/ Regulatory Affairs- Apply Now. Job Description. Openings for QC/ Engineering / QA/ Microbiology/ Regulatory Affairs @ Makcur Laboratories Ltd. Departments: QC/ Engineering / QA/ Microbiology/ Regulatory Affairs. Education: Diploma / Degree/ B.Sc/ M.Sc/ B.Pharm/ M.Pharm. Experience: 01 to 06 years.

article thumbnail

Drug Solutions Podcast: Pharma Trends Dissected by 3 PR Agency Luminaries

PharmaTech

Public relations agencies dissect pharmaceutical trends: Brandwidth Solutions, Orientation Marketing and White Matter Communications.

Pharma 96
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Dr. Reddy’s Laboratories Ltd.-Hiring B.Sc/ M.Sc for Quality Control/ AQA-Formulations Departments -Apply Now

Pharma Pathway

Dr. Reddy’s Laboratories Ltd.-Hiring B.Sc/ M.Sc for Quality Control/ AQA-Formulations Departments -Apply Now. Job Description. Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products.

article thumbnail

Pharmapack Europe to launch two new zones in 2024

European Pharmaceutical Review

In 2024, Pharmapack Europe, the two-day exhibition and conference for pharma’s drug delivery and packaging industry will introduce two brand new zones to the flagship event. The new Packaging Services and Bio packaging zones are intended to meet the growing demand for specialist biological packaging and Contract Packaging Organisations (CPO). “To help the industry find their perfect partners and to sustain [demand] growth we are introducing dedicated zones to accommodate exhibitors specialised i

article thumbnail

Optimus Drugs Pvt. Ltd.-Walk-In Interview for Quality Control/ Microbiology 11th Jan’ 2023

Pharma Pathway

Optimus Drugs Pvt. Ltd.-Walk-In Interview for Quality Control/ Microbiology 11th Jan’ 2023. Job Description. Optimus Drugs Pvt. Ltd was Established in the year 2004 as Custom synthesis laboratory by a team of Technocrats. It is one off the fastest growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and dosages. We expanded into global markets and started filling DMFs for both APIs and Intermediates with Various Regulatory agencies.

article thumbnail

SIFI and Avanzanite announce AKANTIOR agreement

PharmaTimes

Partnership offers treatment access to hundreds of patients across several European countries

Patients 103
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.